In focus
Latest feed
Investor Optimism Fuels Roche's Ascent Amidst Nuanced H1 2026 Report
Sarepta's Shares Climb as Critical Safety Study for Elevidys Gene Therapy Kicks Off
The Million-Dollar Question: Unpacking the FDA Chief's Gene Therapy Warning
A Legal Storm Brews: Sarepta's Groundbreaking Muscular Dystrophy Therapy Faces Renewed Patent Challenge
